SCHEMBL7111437

SCHEMBL7111437

CC(CCC(=O)O)(C(=O)O)P(=O)(O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAALAD2 Q9Y3Q0 1/20 0.44
ALDH1A1 P00352 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP1A2 P05177 1/20 0.41
THRB P10828 1/20 0.41
ESR1 P03372 1/20 0.36
CYP3A4 P08684 1/20 0.36
ESR2 Q92731 1/20 0.36
TSHR P16473 3/20 0.34
HIF1A Q16665 2/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
LMNA P02545 4/20 0.33
FOLH1 Q04609 2/20 0.33
FFAR3 O14843 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8017479 0.88 FOLH1 (0.39) NAALAD2ALDH1A1MEN1KMT2AESR1
SCHEMBL3382753 0.85 NAALAD2 (0.42) NAALAD2ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL3380551 0.82 ALDH1A1 (0.41) NAALAD2ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL8585562 0.82 NAALAD2 (0.40) NAALAD2ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL8460189 0.80 ALDH1A1 (0.40) NAALAD2ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL12931443 0.80 FDPS (0.48) FDPS
SCHEMBL3380370 0.79 ALDH1A1 (0.39) NAALAD2ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL11489691 0.78 GRM4 (0.50) ALDH1A1MEN1KMT2ATSHRLMNA
SCHEMBL871609 0.77 TSHR (0.48) ALDH1A1MEN1KMT2ATSHRHIF1A
SCHEMBL11296652 0.77 FDPS (0.50) FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1346225-A2 METHOD FOR IDENTIFYING SUBSTANCES WHICH POSITIVELY INFLUENCE INFLAMMATORY CONDITIONS OF CHRONIC INFLAMMATORY AIRWAY DISEASES Boehringer Ingelheim Pharma GmbH & Co.KG (DE) 2003-09-24 EP disclosed
US-20020137099-A1 Methods for identifying substances for treating inflammatory conditions BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-09-26 US disclosed
WO-2002052269-A2 METHOD FOR IDENTIFYING SUBSTANCES WHICH POSITIVELY INFLUENCE INFLAMMATORY CONDITIONS OF CHRONIC INFLAMMATORY AIRWAY DISEASES BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2002-07-04 WO disclosed
US-5273549-A Crosslinking agent containing at least two carboxyl groups and a phosphate group SOCIETE FRANCAISE HOECHST (FR) 1993-12-28 US disclosed